NK-One Therapeutics, Inc. — Form D

NK-One Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-27. The offering totals $310K, of which $290K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-04-27
• Form: D
• Accession: 0002127553-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $310K
• Amount sold: $290K
• Remaining: $20K
• Investors: 7
• Revenue range: Decline to Disclose
• SEC file number: 021-581982

Issuer

• Name: NK-One Therapeutics, Inc.
• CIK: 0002127553
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 526 PARK RIDGE DRIVE, WAYNE, PA, 19087
• Phone: 610-733-0446

Officers, directors & promoters (2)

More

• CIK 2127553 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search